Hunt Anthony

CIK 1606030
Transactions on file
42

Tickers traded

Recent activity

FiledTxn dateIssuerRolesCodeSharesValue% since FilingFiling
2026-06-122026-06-10MASS
908 Devices Inc.
Exer.14,083$0.00open →
2025-02-252025-02-24RGEN
REPLIGEN CORP
Director
Tax2,380$392.1K-19.9%open →
2025-02-282025-02-27RGEN
REPLIGEN CORP
Director
Tax2,825$442.2K-15.7%open →
2025-03-042025-03-03RGEN
REPLIGEN CORP
Director
Tax10,142$1.58M-15.1%open →
2025-03-042025-03-02MASS
908 Devices Inc.
Director
Exer.2,058open →
2025-03-192025-03-17RGEN
REPLIGEN CORP
Director
Exer.21,756$1.29M+121.7%open →
2025-03-192025-03-17RGEN
REPLIGEN CORP
Director
Exer.5,000$169.3K+289.6%open →
2025-03-192025-03-17RGEN
REPLIGEN CORP
Director
Sale60$8.9K-10.9%open →
2025-03-192025-03-17RGEN
REPLIGEN CORP
Director
Sale100$15.0K-12.2%open →
2025-03-192025-03-17RGEN
REPLIGEN CORP
Director
Sale2,518$380.4K-12.7%open →
2025-03-192025-03-17RGEN
REPLIGEN CORP
Director
Sale6,176$938.5K-13.2%open →
2025-03-192025-03-17RGEN
REPLIGEN CORP
Director
Sale15,619$2.39M-13.7%open →
2025-03-192025-03-17RGEN
REPLIGEN CORP
Director
Sale2,283$350.9K-14.1%open →
2025-03-202025-03-18BLFS
BIOLIFE SOLUTIONS INC
Director
Grant6,876open →
2025-05-162025-05-15RGEN
REPLIGEN CORP
Director
Sale6,533$812.3K+6.1%open →
2025-05-162025-05-15RGEN
REPLIGEN CORP
Director
Sale268$33.6K+5.4%open →
2025-05-162025-05-15RGEN
REPLIGEN CORP
Director
Sale7$889.00+3.9%open →
2025-05-162025-05-15RGEN
REPLIGEN CORP
Director
Sale17,596$2.17M+6.8%open →
2025-05-162025-05-15RGEN
REPLIGEN CORP
Director
Sale2,043$250.6K+7.6%open →
2025-06-132025-06-11MASS
908 Devices Inc.
Director
Exer.11,364open →
2025-12-082025-12-04RGEN
REPLIGEN CORP
Other2,000$0.00open →
2025-11-142025-11-13RGEN
REPLIGEN CORP
Exer.2,952$100.0K+289.6%open →
2025-11-142025-11-13RGEN
REPLIGEN CORP
Sale1,956$307.3K-16.0%open →
2025-11-142025-11-13RGEN
REPLIGEN CORP
Sale5,737$896.2K-15.5%open →
2025-11-142025-11-13RGEN
REPLIGEN CORP
Sale3,000$466.3K-15.1%open →
2025-11-142025-11-13RGEN
REPLIGEN CORP
Sale2,500$385.8K-14.5%open →
2025-11-142025-11-13RGEN
REPLIGEN CORP
Sale2,923$447.6K-13.8%open →
2025-11-142025-11-13RGEN
REPLIGEN CORP
Sale2,100$319.6K-13.3%open →
2025-11-142025-11-13RGEN
REPLIGEN CORP
Sale1,784$269.4K-12.6%open →
2025-11-132025-11-12RGEN
REPLIGEN CORP
Sale464$73.5K-16.7%open →
2025-11-132025-11-12RGEN
REPLIGEN CORP
Sale11,096$1.75M-16.5%open →
2025-11-132025-11-12RGEN
REPLIGEN CORP
Sale4,959$776.8K-15.8%open →
2025-11-132025-11-12RGEN
REPLIGEN CORP
Sale4,740$738.7K-15.3%open →
2025-11-132025-11-12RGEN
REPLIGEN CORP
Sale3,741$579.6K-14.8%open →
2025-11-132025-11-12RGEN
REPLIGEN CORP
Exer.25,000$846.7K+289.6%open →
2025-09-112025-09-10RGEN
REPLIGEN CORP
Director
Sale7,584$920.8K+8.7%open →
2025-09-112025-09-10RGEN
REPLIGEN CORP
Director
Sale3,262$390.3K+10.3%open →
2025-09-112025-09-10RGEN
REPLIGEN CORP
Director
Sale2,179$266.3K+8.0%open →
2025-09-112025-09-10RGEN
REPLIGEN CORP
Director
Exer.20,000$677.4K+289.6%open →
2025-09-112025-09-10RGEN
REPLIGEN CORP
Director
Sale96$11.2K+13.4%open →
2025-09-112025-09-10RGEN
REPLIGEN CORP
Director
Sale1,108$131.1K+11.5%open →
2025-09-112025-09-10RGEN
REPLIGEN CORP
Director
Sale14,882$1.79M+9.8%open →